Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease
- PMID: 1082003
Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease
Abstract
Crossed antigen-antibody electrophoresis was used to determine the electrophoretic properties of factor VIII/Von Willebrand (F. VIII/VW) protein in normal plasma using a specific rabbit antiserum against purified human factor VIII. The electrohoretic patterns in seven patients with severe Von Willebrand's disease in two different families were studied. In these patients the prolonged bleeding time was related to a functionally abnormal F. VIII/VW protein which was unable to induce platelet aggregation in presence of ristocetin. F. VIII/VW protein had an increased electrophoretic mobility in all the patients. The electrophoretic pattern was similar in different members of the same family but differed from one family to the other. Plasma samples collected after transfusion of normal cryoprecipitate to one member of the first family showed an increasing amount of F. VIII/VW protein, but even one hour after transfusion only one peak migration in an abnormal position was found. However, when mixed in vitro with normal plasma, the plasmas of the same patient showed two peaks, one in position of normal F. VIII/VW protein and one with increased electrophoretic mobility. These results suggest that normal F. VIII/VW protein transfused to recipients with Von Willebrand's disease synthesizing a functionally deficient factor undergoes a rapid alteration.
Similar articles
-
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.J Clin Invest. 1977 Aug;60(2):390-404. doi: 10.1172/JCI108788. J Clin Invest. 1977. PMID: 17621 Free PMC article.
-
Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.Thromb Haemost. 1976 Feb 29;35(1):110-9. Thromb Haemost. 1976. PMID: 1085498
-
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.J Clin Invest. 1975 Oct;56(4):814-27. doi: 10.1172/JCI108160. J Clin Invest. 1975. PMID: 1080491 Free PMC article.
-
Treatment of von Willebrand's disease.J Intern Med Suppl. 1997;740:129-32. J Intern Med Suppl. 1997. PMID: 9350194 Review.
-
Von Willebrand's disease.Prog Hemost Thromb. 1976;3:231-87. Prog Hemost Thromb. 1976. PMID: 781732 Review. No abstract available.
Cited by
-
Structural analysis of factor VIII antigen in von Willebrand disease.Proc Natl Acad Sci U S A. 1980 Nov;77(11):6832-6. doi: 10.1073/pnas.77.11.6832. Proc Natl Acad Sci U S A. 1980. PMID: 6161373 Free PMC article.
-
The von Willebrand-syndrome.Blut. 1983 Sep;47(3):123-30. doi: 10.1007/BF00320173. Blut. 1983. PMID: 6411153 No abstract available.
-
[A variant of the von Willebrand-Jürgens-syndrome with abnormalities of the factor VIII/von Willebrand factor protein (author's transl)].Blut. 1979 Jan 22;38(1):25-34. doi: 10.1007/BF01082925. Blut. 1979. PMID: 310328 German.
-
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.J Clin Invest. 1977 Aug;60(2):390-404. doi: 10.1172/JCI108788. J Clin Invest. 1977. PMID: 17621 Free PMC article.
-
Von Willebrand's disease: a clinical and molecular enigma. Twelfth Annual Paul M. Aggeler Memorial Lecture.West J Med. 1982 Apr;136(4):318-25. West J Med. 1982. PMID: 6806985 Free PMC article. No abstract available.